Live from the NIH registry
Studies recruiting near Fayetteville right now
Top 25 of 126 recruiting studies, sorted by proximity — each links to its official registry page
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Highlands Oncology Group (HOG) — Springdale, Arkansas (8.2 mi)
· Sponsor: Paradigm Health
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Highlands Oncology Group, PA — Fayetteville, Arkansas (0.8 mi)
· Sponsor: Pfizer
Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study
Decision-Making, Patient Care
Phase 2
Interventional 210 participants sought
University of Arkansas for Medical Sciences — Fayetteville, Arkansas (0.8 mi)
· Sponsor: University of Arkansas, Fayetteville
Combining a Smartphone App With Medications to Manage Heavy Drinking
Alcohol Use Disorder (AUD)
N/A
Interventional 330 participants sought
Veterans Health Care System of the Ozarks, Fayetteville, AR — Fayetteville, Arkansas (0.8 mi)
· Sponsor: VA Office of Research and Development
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
University of Arkansas — Fayetteville, Arkansas (0.8 mi)
· Sponsor: Parkinson's Foundation
Targeting Components of Distress Tolerance
Distress, Emotional
N/A
Interventional 240 participants sought
University of Arkansas - Fayetteville — Fayetteville, Arkansas (0.8 mi)
· Sponsor: University of Arkansas, Fayetteville
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi)
· Sponsor: Bristol-Myers Squibb
Appetite Response to Meals With Different Protein Sources in Women With PCOS
Polycystic Ovary Syndrome (PCOS)
N/A
Interventional 30 participants sought
Center for Human Nutrition — Fayetteville, Arkansas (0.8 mi)
· Sponsor: University of Arkansas, Fayetteville
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Phase 1
Interventional 258 participants sought
Highlands Oncology Group, PA — Springdale, Arkansas (8.2 mi)
· Sponsor: Shanghai Henlius Biotech
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Muscle-invasive Urothelial Carcinoma
Phase 2
Interventional 62 participants sought
Highlands Oncology Group. — Springdale, Arkansas (8.2 mi)
· Sponsor: Hoffmann-La Roche
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Phase 2, Phase 3
Interventional 590 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi)
· Sponsor: Bristol-Myers Squibb
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Eosinophilic Gastrointestinal Disorders (EGIDs), Eosinophilic Esophagitis
N/A
Observational 1,350 participants sought
Arkansas Children's Research Institute — Rogers, Arkansas (18.2 mi)
· Sponsor: Children's Hospital Medical Center, Cincinnati
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 744 participants sought
Research Site — Fayetteville, Arkansas (0.8 mi)
· Sponsor: AstraZeneca
Time Restricted Feeding, Muscle, and Metabolism
Overweight, Obesity
N/A
Interventional 90 participants sought
University of Arkansas — Fayetteville, Arkansas (0.8 mi)
· Sponsor: University of Arkansas, Fayetteville
The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
Attention-Deficit/Hyperactivity Disorder
Phase 2
Interventional 76 participants sought
University of Arkansas — Fayetteville, Arkansas (0.8 mi)
· Sponsor: University of Arkansas, Fayetteville
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Highlands Oncology Group - Springdale — Springdale, Arkansas (8.2 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Metastatic Castration-Resistant Prostate Cancer
Phase 3
Interventional 900 participants sought
Highlands Oncology — Fayetteville, Arkansas (0.8 mi)
· Sponsor: Pfizer
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Major Depressive Disorder
Phase 3
Interventional 450 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi)
· Sponsor: Xenon Pharmaceuticals Inc.
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Attention-Deficit/Hyperactivity Disorder
Phase 4
Interventional 286 participants sought
Preferred Research Partners-NWA, LLC — Fayetteville, Arkansas (0.8 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Springdale, Arkansas (8.2 mi)
· Sponsor: AstraZeneca
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Breast Neoplasms
Phase 3
Interventional 558 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi)
· Sponsor: BioNTech SE
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Bipolar 1 Disorder
Phase 2
Interventional 250 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi)
· Sponsor: Rapport Therapeutics Inc.
Protein and Polycystic Ovary Syndrome (PCOS)
Polycystic Ovary Syndrome (PCOS)
N/A
Interventional 60 participants sought
Center for Human Nutrition — Fayetteville, Arkansas (0.8 mi)
· Sponsor: University of Arkansas, Fayetteville
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia
N/A
Observational 300 participants sought
Arkansas Children's Northwest — Springdale, Arkansas (8.2 mi)
· Sponsor: Arkansas Children's Hospital Research Institute